Skip to content
Open access

Skin dosimetry in megavoltage radiotherapy using hydrogenated amorphous silicon on a tissue-equivalent flexible substrate

Jul 2026 · Physics in Medicine and Biology · Vol 71, pp. 155020 · 0 citations · 30 references
Physics Medicine

TL;DR

This study demonstrates that a-Si:H sensors on flexible plastic substrates have a potential for accurate surface dose measurements and agree with reference detectors and this thin, flexible detector provides real time measurements and is stable under high radiation doses.

Abstract

Acute skin toxicity after radiation treatments highlights the need for improved dose monitoring and measurement, as the treatment planning system does not accurately estimate skin dose. Wearable radiation detectors may be the solution for most in vivo dosimetry needs, but they require innovative materials. The purpose of this work is to overcome the challenges that limit accurate skin dosimetry by exploring the use of hydrogenated amorphous silicon (a-Si:H) fabricated on a flexible polyimide substrate for direct radiation detection. The a-Si:H detector was fabricated on a 125 μm polyimide substrate with a thickness of 3.6–10 μm. The detector’s response to the build-up region of the percentage depth dose (PDD) of the MV photon beam was compared to Geant4 radiation transport simulations and benchmarked to Attix ionization chamber measurements. Angular dependency and surface field factors at the phantom surface were compared to Attix IC. The PDD measurement is within 2% of Geant4’s simulation and the Attix chamber’s response from 150 μ m to 25 mm in a plastic water phantom. All samples showed linear dose responses with 0.37% reproducibility. The a-Si:H device matches the Attix chamber for surface field factor measurements (6–10 MV photon beams, for 5 to 25 cm field sizes). The angular dependence (−60° to +60°) compared to the Attix IC confirms the sensor’s WED of 150 ± 5 µm. This study demonstrates that a-Si:H sensors on flexible plastic substrates have a potential for accurate surface dose measurements and agree with reference detectors. This thin, flexible detector provides real time measurements and is stable under high radiation doses. The possibility to assemble with ease an array of a-Si:H pixels over large areas with different sizes and shapes, makes this technology attractive for in vivo dosimetry.

Read PDF

Similar papers

Conference Open access Sep 2026

Evaluation of a New Detector Design for Measuring Superficial 2D Dose Distributions in Proton Therapy for Skin Cancer

Each year, the incidence of skin cancer continues to rise worldwide. Radiotherapy remains a well-established treatment option; however, its effectiveness can be limited by technical constraints. In clinical practice, a water-equivalent material known as a bolus is often placed over the tumor site to restore electronic...

G. Tosetti, J. Fontbonne, D. Lebhertz et al. · 0 citations
Conference Open access Sep 2026

Dosimetric assessment of radiation fields up to 5 × 5 cm2 and architectural optimization of a diode-based 3D Detector for radiotherapy

An initial 3D electronic detector array prototype for radiotherapy, consisting of 2645 diodes (8.0 mm pitch), was modelled with Geant4 and MCNP6.2 Monte Carlo codes to simulate irradiations of 2×2, 3×3, 4×4, and 5×5 cm2 field sizes with a 6 MV photon beam. Comparisons with Treatment Planning Software (TPS) data reveale...

R. Ocampo, D. Roa, Enzo Aucca et al. · 0 citations
Sep 2026

Validation of a detector-response correction model for in vivo dosimetry in high-dose-rate prostate brachytherapy.

BACKGROUND High-dose-rate brachytherapy (HDRBT) is an established treatment for localized prostate cancer. Despite its efficacy, HDRBT can exhibit dosimetric discrepancies between planned and delivered doses. In vivo dosimetry (IVD) using metal-oxide-semiconductor field-effect transistors (MOSFETs) enables real-time mo...

S. Ruiz-Arrebola, D. Guirado, Rosa Fabregat-Borrás et al. · 0 citations
Oct 2026

Investigating the behavior of hydrogenated amorphous silicon under UHDR proton beam

Radiation-based therapies are crucial treatments in the fight against malignant cancers. Ultra-high dose rate (UHDR) proton therapy promises a higher radiobiological advantage and increased effectiveness in targeting tumor cells while sparing healthy cells by providing the total dose in a short time at a rate higher th...

K. El Achi, A. Warnier, A. Khalilzadeh et al. · 0 citations
Open access Aug 2026

Response of a Commercial MOSFET to Clinical Photon and Electron Beams Used in Radiotherapy

One type of dosimeter used in radiotherapy is the metal-oxide-semiconductor field-effect transistor (MOSFET), which is widely employed in in vivo dosimetry. This study investigated the response of a commercial MOSFET (STQ2HNK60ZR-AP) to photon and electron beams from a clinical linear accelerator. Radiation damage is t...

Luiz Flavio Kalil Telles, L. M. Maria, D. Souza et al. · 0 citations
Open access Sep 2026

Study of three-dimensional dose distribution measurement of ultra-high dose rate electron beam

Objective. FLASH radiotherapy which employs an ultra-high dose rate (UHDR) ( >40 Gy s −1), effectively protects normal tissues and organs while maintaining robust tumor control. However, it also presents serious challenges for quality assurance (QA). Currently, dosimeters face various limitations under FLASH radiothera...

Wei Zhang, Chang Cheng, Rong-Hu Mao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.